Mitch Zeller: The past, present and future of nicotine addiction
Mitch Zeller leads the US Food and Drug Administration's efforts to reduce disease and death from tobacco use and bring previously unavailable information about its dangers to light. Full bio
Double-click the English transcript below to play the video.
consumer product imaginable
prematurely, later in life.
at the Food and Drug Administration,
the work that we're doing
of creating or sustaining addiction.
the tobacco problem or the smoking problem
that's been made
consumption and prevalence.
who continue to smoke
that tobacco use,
and secondhand exposure
preventable disease and death
that it's actually killing more people
to be the case ever before?
than alcohol, AIDS, car accidents,
and suicides combined.
Surgeon General's report
death toll from smoking,
of smoking-related illnesses
480,000 Americans every year.
a statistic like this?
at this conference
and personal experiences.
at a population level,
every year from tobacco?
when you think about this trajectory
Surgeon General's report five years ago,
avoidable deaths in the United States
alive in the United States in 2014
because of cigarettes.
public health problem for all of us
and the Center for Tobacco Products.
of disease and death?
to help unravel issues
as we know it come to be?
of the tobacco and cigarette business?
unregulated marketplace?
from the tobacco industry.
document time machine.
was finally able to conclude
and cigarettes was addictive.
the Surgeon General's report in 1998.
Surgeon General's report in 1964.
the Surgeon General's report,
in Brooklyn, New York.
in the United States smoked.
were heavy smokers at the time.
Virginia or Kentucky,
in arts and crafts class.
but they were ashtrays.
a bowl of loose cigarettes in the foyer
when friends came over for a visit.
cigarette company in the United States,
of selling nicotine -- an addictive drug."
as for what it does say.
in the cigarette business.
in the tobacco business.
of selling nicotine.
for a day's supply of nicotine.
for a dose unit of nicotine."
dose unit notion later.
may be thought of as being a specialized,
of the pharmaceutical industry.
contain and deliver nicotine,
of physiological effects."
decades, publicly,
of their business.
made public about cigarettes,
unregulated marketplace?
that heavily featured imagery of doctors
of the time in the '30s:
say "Luckies are less irritating."
against irritation, against cough.]
a health message of reassurance.
in the absence of regulation,
is modifications to the product
concerns of the day.
was the filtered cigarette.
health protection ever.]
of this product didn't know,
that was lined with asbestos --
were smoking this filtered cigarette
with cancer and lung disease
asbestos fibers.
was the light cigarette.
of the day called True.
reports have started coming out.
of concern on her face.
or smoke True.
in the small print
of the product modification
of laser-perforated ventilation holes
should be 12 millimeters
puffing away on the cigarette
those ventilation holes
that was coming through the cigarette.
and nicotine being delivered
don't smoke like machines.
from the lip end.
they were there,
the holes get blocked.
it's no longer a light cigarette.
inside a light cigarette
of regulating tobacco products
at the beginning
to disease and death that cigarettes make.
as a drug-delivery device
with which it delivers nicotine.
gets up into the brain
called "nicotinic receptors."
of that Philip Morris document,
the symptoms of withdrawal.
are a chemical message
are sending to the body,
in less than 10 seconds
and incredibly addictive product.
addiction treatment experts
over and over again:
to get somebody off of heroin
is the 10-second thing.
minimally or nonaddictive.
impact at a population level
modeling a year ago,
in "The New England Journal."
effect of this policy,
through the end of the century:
to become regular smokers won't,
that they'll be experimenting with
down to less than one and a half percent.
eight million cigarette-related deaths
started smoking when they were kids.
to buy a pack of cigarettes.
before they were 18 years old.
about a product
prematurely later in life.
of this nicotine-reduction policy
had a word for young people.
"the replacement smokers."
for addicted adult smokers
especially teens,
that they could get their hands on
or sustain addiction?
return on investment
about e-cigarettes.
of kids' use of e-cigarettes.
when it comes to prevalence,
20 or more days in the past 30 days
came onto the market.
everything that we can
aren't initiating and experimenting
in a properly regulated marketplace
away from cigarettes.
that future generations of kids
or sustain addiction
to minimally or nonaddictive levels,
and less harmful forms
nicotine medications,
regulated marketplace,
or whatever the technology of the day,
and the marketers
that Congress has entrusted us
should come to market,
and the words of our law
of the public health.
of powerful regulatory tools
preventable disease and death
those 5.6 million kids,
ABOUT THE SPEAKER
Mitch Zeller - Health policy expertMitch Zeller leads the US Food and Drug Administration's efforts to reduce disease and death from tobacco use and bring previously unavailable information about its dangers to light.
Why you should listen
As director of the Center for Tobacco Products (CTP), Mitch Zeller, JD, is dedicated to carrying out CTP's charge to reduce the harm from all tobacco products across the entire population -- with a focus on how and why people start, stop or start using these products again.
Zeller became director of the FDA's Center for Tobacco Products in March 2013. The mission of CTP -- established by enactment of the 2009 Family Smoking Prevention and Tobacco Control Act -- is "to make tobacco-related death and disease part of America's past, not America's future, and, by doing so, ensure a healthier life for every American family."
A graduate of Dartmouth College and the American University Washington College of Law, Zeller has been working on FDA issues for more than 30 years. He began his career as a public interest attorney in 1982 at the Center for Science in the Public Interest (CSPI). In 1988, Zeller left CSPI to become counsel to the Human Resources and Intergovernmental Relations Subcommittee of the House of Representatives Government Operations Committee, where he conducted oversight of enforcement of federal health and safety laws.
In 1993, Zeller joined the staff of then-FDA Commissioner Dr. David Kessler, MD. What began as a two-week assignment by Kessler in 1994 to examine the practices of the tobacco industry led to his serving as associate commissioner and director of FDA's first Office of Tobacco Programs. Instrumental in crafting the agency's 1996 tobacco regulations, Zeller also represented FDA before Congress, federal and state agencies. Zeller also served as an official US delegate to the World Health Organization (WHO) Working Group for the Framework Convention on Tobacco Control.
In 2000, Zeller left FDA to continue his work for tobacco control as executive vice president of the American Legacy Foundation. His responsibilities there included marketing, communications, strategic partnerships and creating the foundation's first Office of Policy and Government Relations. In 2002, Zeller joined Pinney Associates where, as senior vice president, he provided strategic planning and communications advice on domestic and global public health policy issues involving the treatment of tobacco dependence and the regulation of tobacco products and pharmaceuticals.
Mitch Zeller | Speaker | TED.com